메뉴 건너뛰기




Volumn 5, Issue 2, 2014, Pages 162-185

Bayesian network meta-analysis for unordered categorical outcomes with incomplete data

Author keywords

Correlated outcomes; Markov chain Monte Carlo; Missing data; Multinomial distribution; Multiple treatments meta analysis; Statin therapy

Indexed keywords

BAYES THEOREM; COMPUTER SIMULATION; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PROCEDURES; SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICAL MODEL;

EID: 84938692431     PISSN: 17592879     EISSN: 17592887     Source Type: Journal    
DOI: 10.1002/jrsm.1103     Document Type: Article
Times cited : (18)

References (42)
  • 2
    • 0037132607 scopus 로고    scopus 로고
    • Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to Pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
    • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. 2002. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to Pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 288(23): 2998-3007.
    • (2002) JAMA , vol.288 , Issue.23 , pp. 2998-3007
  • 4
    • 4344683381 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
    • Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH. 2004. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364(9435): 685-696.
    • (2004) Lancet , vol.364 , Issue.9435 , pp. 685-696
    • Colhoun, H.M.1    Betteridge, D.J.2    Durrington, P.N.3    Hitman, G.A.4    Neil, H.A.5    Livingstone, S.J.6    Thomason, M.J.7    Mackness, M.I.8    Charlton-Menys, V.9    Fuller, J.H.10
  • 5
    • 69949092149 scopus 로고    scopus 로고
    • Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation
    • Cooper NJ, Sutton AJ, Morris D, Ades AE, Welton NJ. 2009. Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Stat Med 28(14): 1861-1881.
    • (2009) Stat Med , vol.28 , Issue.14 , pp. 1861-1881
    • Cooper, N.J.1    Sutton, A.J.2    Morris, D.3    Ades, A.E.4    Welton, N.J.5
  • 7
    • 84879740382 scopus 로고    scopus 로고
    • Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials
    • Dias S, Sutton AJ, Ades AE, Welton NJ. 2013. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making 33(5): 607-617.
    • (2013) Med Decis Making , vol.33 , Issue.5 , pp. 607-617
    • Dias, S.1    Sutton, A.J.2    Ades, A.E.3    Welton, N.J.4
  • 8
    • 0032572086 scopus 로고    scopus 로고
    • Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
    • Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM, Jr. 1998. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279(20): 1615-1622.
    • (1998) JAMA , vol.279 , Issue.20 , pp. 1615-1622
    • Downs, J.R.1    Clearfield, M.2    Weis, S.3    Whitney, E.4    Shapiro, D.R.5    Beere, P.A.6    Langendorfer, A.7    Stein, E.A.8    Kruyer, W.9    Gotto, A.M.10
  • 9
    • 84867086419 scopus 로고    scopus 로고
    • Prior distributions for variance parameters in hierarchical models
    • Gelman A. 2006. Prior distributions for variance parameters in hierarchical models. Bayesian Analysis 1(3): 515-533.
    • (2006) Bayesian Analysis , vol.1 , Issue.3 , pp. 515-533
    • Gelman, A.1
  • 10
    • 84959390204 scopus 로고    scopus 로고
    • Bayesian data analysis. 2nd ed. Chapman & Hall/CRC; 2004.
    • Gelman A, Carlin JB, Stern HS, Rubin DB. 2004. Bayesian data analysis. 2nd ed. Chapman & Hall/CRC; 2004.
    • (2004)
    • Gelman, A.1    Carlin, J.B.2    Stern, H.S.3    Rubin, D.B.4
  • 11
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group. 2002. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360(9326): 7-22.
    • (2002) Lancet , vol.360 , Issue.9326 , pp. 7-22
  • 12
    • 0030463880 scopus 로고    scopus 로고
    • Borrowing strength from external trials in a meta-analysis
    • Higgins JP, Whitehead A. 1996. Borrowing strength from external trials in a meta-analysis. Stat Med 15(24): 2733-2749.
    • (1996) Stat Med , vol.15 , Issue.24 , pp. 2733-2749
    • Higgins, J.P.1    Whitehead, A.2
  • 13
    • 80051781370 scopus 로고    scopus 로고
    • Multivariate meta-analysis: potential and promise
    • Jackson D, Riley R, White IR. 2011. Multivariate meta-analysis: potential and promise. Stat Med 30(20): 2481-2498.
    • (2011) Stat Med , vol.30 , Issue.20 , pp. 2481-2498
    • Jackson, D.1    Riley, R.2    White, I.R.3
  • 14
    • 84868322973 scopus 로고    scopus 로고
    • Meta-analysis: lowering LDL-C levels using statins reduces major vascular events regardless of baseline risk
    • Jain M, Rosenberg M. 2012. Meta-analysis: lowering LDL-C levels using statins reduces major vascular events regardless of baseline risk. Ann Intern Med 157(8): JC4-2.
    • (2012) Ann Intern Med , vol.157 , Issue.8 , pp. JC4-JC2
    • Jain, M.1    Rosenberg, M.2
  • 15
    • 84865295846 scopus 로고    scopus 로고
    • A multivariate meta-analysis approach for reducing the impact of outcome reporting bias in systematic reviews
    • Kirkham JJ, Riley RD, Williamson PR. 2012. A multivariate meta-analysis approach for reducing the impact of outcome reporting bias in systematic reviews. Stat Med 31(20): 2179-2195.
    • (2012) Stat Med , vol.31 , Issue.20 , pp. 2179-2195
    • Kirkham, J.J.1    Riley, R.D.2    Williamson, P.R.3
  • 16
    • 33746431474 scopus 로고    scopus 로고
    • Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)
    • Knopp RH, d'Emden M, Smilde JG, Pocock SJ. 2006. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN). Diabetes Care 29(7): 1478-1485.
    • (2006) Diabetes Care , vol.29 , Issue.7 , pp. 1478-1485
    • Knopp, R.H.1    d'Emden, M.2    Smilde, J.G.3    Pocock, S.J.4
  • 17
    • 23244434820 scopus 로고    scopus 로고
    • How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS
    • Lambert PC, Sutton AJ, Burton PR, Abrams KR, Jones DR. 2005. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Stat Med 24(15): 2401-2428.
    • (2005) Stat Med , vol.24 , Issue.15 , pp. 2401-2428
    • Lambert, P.C.1    Sutton, A.J.2    Burton, P.R.3    Abrams, K.R.4    Jones, D.R.5
  • 19
    • 33745663057 scopus 로고    scopus 로고
    • Assessing evidence inconsistency in mixed treatment comparisons
    • Lu G, Ades A. 2006. Assessing evidence inconsistency in mixed treatment comparisons. J Am Stat Assoc 101(474): 447-459.
    • (2006) J Am Stat Assoc , vol.101 , Issue.474 , pp. 447-459
    • Lu, G.1    Ades, A.2
  • 20
    • 74349083543 scopus 로고    scopus 로고
    • Modeling between-trial variance structure in mixed treatment comparisons
    • Lu G, Ades A. 2009. Modeling between-trial variance structure in mixed treatment comparisons. Biostatistics 10(4): 792-805.
    • (2009) Biostatistics , vol.10 , Issue.4 , pp. 792-805
    • Lu, G.1    Ades, A.2
  • 22
    • 84876708207 scopus 로고    scopus 로고
    • A practical introduction to multivariate meta-analysis
    • Mavridis D, Salanti G. 2013. A practical introduction to multivariate meta-analysis. Stat Methods Med Res 22(2): 133-158.
    • (2013) Stat Methods Med Res , vol.22 , Issue.2 , pp. 133-158
    • Mavridis, D.1    Salanti, G.2
  • 26
    • 21444460810 scopus 로고    scopus 로고
    • Unconstrained parameterizations for variance-covariance matrices
    • Pinheiro JC, Bates DM. 1996. Unconstrained parameterizations for variance-covariance matrices. Stat Comput 6: 289-296.
    • (1996) Stat Comput , vol.6 , pp. 289-296
    • Pinheiro, J.C.1    Bates, D.M.2
  • 28
    • 84959390207 scopus 로고    scopus 로고
    • R package rjags [computer program]. Version 3.3.
    • Plummer M. 2013. R package rjags [computer program]. Version 3.3.
    • (2013)
    • Plummer, M.1
  • 30
    • 70349508931 scopus 로고    scopus 로고
    • Multivariate meta-analysis: the effect of ignoring within-study correlation
    • Riley RD. 2009. Multivariate meta-analysis: the effect of ignoring within-study correlation. J Royal Stat Soc A 172(4): 789-811.
    • (2009) J Royal Stat Soc A , vol.172 , Issue.4 , pp. 789-811
    • Riley, R.D.1
  • 32
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
    • Scandinavian Simvastatin Survival Study Group. 1994. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344(8934): 1383-1389.
    • (1994) Lancet , vol.344 , Issue.8934 , pp. 1383-1389
  • 34
    • 10644259543 scopus 로고    scopus 로고
    • Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
    • Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J. 2004. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Drugs 64 Suppl 2: 43-60.
    • (2004) Drugs , vol.64 , pp. 43-60
    • Sever, P.S.1    Dahlof, B.2    Poulter, N.R.3    Wedel, H.4    Beevers, G.5    Caulfield, M.6    Collins, R.7    Kjeldsen, S.E.8    Kristinsson, A.9    McInnes, G.T.10    Mehlsen, J.11    Nieminen, M.12    O'Brien, E.13    Ostergren, J.14
  • 36
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
    • Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333(20): 1301-1307.
    • (1995) N Engl J Med , vol.333 , Issue.20 , pp. 1301-1307
    • Shepherd, J.1    Cobbe, S.M.2    Ford, I.3    Isles, C.G.4    Lorimer, A.R.5    MacFarlane, P.W.6    McKillop, J.H.7    Packard, C.J.8
  • 37
    • 0032487931 scopus 로고    scopus 로고
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
    • The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. 1998. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339(19): 1349-1357.
    • (1998) N Engl J Med , vol.339 , Issue.19 , pp. 1349-1357
  • 38
    • 0031030620 scopus 로고    scopus 로고
    • The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts
    • The Post Coronary Artery Bypass Graft Trial Investigators
    • The Post Coronary Artery Bypass Graft Trial Investigators. 1997. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 336(3): 153-162.
    • (1997) N Engl J Med , vol.336 , Issue.3 , pp. 153-162
  • 40
    • 84959390209 scopus 로고    scopus 로고
    • An empirical comparison of univariate and multivariate meta-analyses for categorical outcomes
    • (in press).
    • Trikalinos TA, Hoaglin DC, Schmid CH. 2013a. An empirical comparison of univariate and multivariate meta-analyses for categorical outcomes. Stat Med (in press).
    • (2013) Stat Med
    • Trikalinos, T.A.1    Hoaglin, D.C.2    Schmid, C.H.3
  • 41
    • 50849135168 scopus 로고    scopus 로고
    • A method for the meta-analysis of mutually exclusive binary outcomes
    • Trikalinos TA, Olkin I. 2008. A method for the meta-analysis of mutually exclusive binary outcomes. Stat Med 27(21): 4279-4300.
    • (2008) Stat Med , vol.27 , Issue.21 , pp. 4279-4300
    • Trikalinos, T.A.1    Olkin, I.2
  • 42
    • 84867524702 scopus 로고    scopus 로고
    • Meta-analysis of effect sizes reported at multiple time points: a multivariate approach
    • Trikalinos TA, Olkin I. 2012. Meta-analysis of effect sizes reported at multiple time points: a multivariate approach. Clin Trials 9(5): 610-620.
    • (2012) Clin Trials , vol.9 , Issue.5 , pp. 610-620
    • Trikalinos, T.A.1    Olkin, I.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.